The Riverside Company completed the investment in MDoutlook.

The Riverside Company, a global private investor focused on the smaller end of the middle market, completed the investment in MDoutlook, a provider of precision intelligence solutions that help life sciences companies develop and commercialize therapeutics and diagnostics in oncology. Financial terms were not disclosed. "MDoutlook’s business intelligence and market research services and CEA’s education platform will allow HCPs to learn and discover novel treatments and engage more deeply in peer-to-peer communications, and create a channel for HCPs to provide feedback to the pharmaceutical community - all with the goal of helping better treat patients. This investment will provide a springboard for future investments in market research and business intelligence as we continue executing upon our growth strategy at CEA," Jason Fulton, Riverside Principal.